EnlivexFRA:1BT 33 FCF Yield % is -8.24 as of Jul. 06, 2026. GuruFocus rates FRA:1BT with a GF Score™ of 33/100. The stock has 2 warning signs investors should review. Among 1,409 Biotechnology companies, Enlivex ranks better than 52.31% on this metric.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
As of today, Enlivex's Trailing 12-Month Free Cash Flow is €-9.30 Mil, and Market Cap is €111.68 Mil. Therefore, Enlivex's FCF Yield % for today is -8.24%.
The historical rank and industry rank for Enlivex's FCF Yield % or its related term are showing as below:
FRA:1BT'
s FCF Yield % Range Over the Past 10 Years
Min: -8.24 Med: 0 Max: 0
Current: -8.24
FRA:1BT's FCF Yield % is ranked better than 52.31% of 1409
companies
in the Biotechnology industry
Industry Median: -9.21
vs FRA:1BT: -8.24
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Enlivex FCF Yield % Related Terms
Enlivex FCF Yield % Historical Data
* Premium members only.
The historical data trend for Enlivex's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:1BT vs CNTB, SMNR, MENS: FCF Yield % Comparison
For the Biotechnology subindustry, Enlivex's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Enlivex FCF Yield % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Enlivex's FCF Yield % distribution charts can be found below:
* The bar in red indicates where Enlivex's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enlivex (FRA:1BT) has a FCF Yield % of -8.24 as of Jul. 06, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Enlivex and its competitors. According to the industry distribution chart, Enlivex ranks #672 out of 1409 companies in the Biotechnology industry, placing it in the top 47.7%.
Is Enlivex's FCF Yield % too high?
Enlivex's current FCF Yield % is -8.24. Based on the distribution chart, Enlivex ranks #672 out of 1409 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Enlivex has a GF Score™ of 33/100, reflecting its overall financial health beyond just this single metric.
How does Enlivex's FCF Yield % compare to CNTB and SMNR?
According to the Biotechnology industry distribution chart, Enlivex ranks #672 out of 1409 companies for FCF Yield %. This puts Enlivex in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Biotechnology company?
A good FCF Yield % depends on the Biotechnology industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Enlivex and its competitors. Enlivex's current FCF Yield % is -8.24. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Enlivex stock overvalued right now?
Enlivex (FRA:1BT) has a current FCF Yield % of -8.24. The current FCF Yield % is -8.24. Enlivex's overall GF Score™ is 33/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Enlivex (FRA:1BT), the current FCF Yield % is -8.24 as of Jul. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Enlivex Ltd is a clinical stage macrophage reprogramming immunotherapy company currently focused on the late-stage clinical development of Allocetra, a novel therapy designed to treat the joint disease osteoarthritis. Additionally, it has developed a treasury using the RAIN protocol, which currently serves as the primary treasury reserve asset of the company.
33GF Score
Get the complete analysis for FRA:1BT
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:1BT has been successfully added to your 
